The ART Lab’s research program builds upon interdisciplinary training in radiochemistry, molecular imaging, radiopharmaceutical therapy, and radiobiology. Specifically, we focus on harnessing the power and versatility of medical radioisotopes to create tools to tackle some of the most challenging problems in the biomedical field.
Our laboratory currently has three broad research topics: (1) the development of radiopharmaceutical agents to treat advanced cancers, (2) the generation of novel molecular imaging tools for disease diagnosis and precision medicine, and (3) understanding the radiobiology of cancer to devise effective innovative treatment strategies.
By design, our research group is diverse in terms of backgrounds and competencies and includes chemists, radiochemists, medical physicists, pharmacologists, and biologists. Our cross-disciplinary nature allows us to attack research questions from a number of perspectives and is conducive to generating unique and innovative paradigms to investigate them.
Notably, integrated into our philosophy is the concept of high stakes and tangible societal impact as guiding principles and driving force for our research efforts. To this end, we have established several partnerships with physician-scientists who provide constant feedback and help guide our bench-to-bedside translational efforts. Our lab is entirely committed to shepherd our most transformative discoveries from inception until early clinical testing.
